Federman & Sherwood Investigates Sibanye-Stillwater for Data Breach
Federman & Sherwood Investigates Sibanye-Stillwater for Data Breach
Federman & Sherwood investigates Sibanye-Stillwater for data breach. On September 14, 2024, Sibanye-Stillwater filed a notice of data breach with the Attorney General’s Office of Maine. Around July 8, 2024, Sibanye-Stillwater discovered unauthorized access to their IT network and immediately launched an investigation. Sibanye-Stillwater still has an ongoing investigation into the incident but determined the unauthorized access occurred mid-June 2024 and involved access to certain individuals personal and sensitive information. Sibanye-Stillwater is a multinational mining and metals processing group
The type of information potentially exposed includes:
- Full name
- Social Security Number
- Date of birth
- Passport number
- Tax ID number
- Financial information
- Health information
- Other sensitive information
If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tiffany Peintner either by email at trp@federmanlaw.com or visit our firm’s website www.federmanlaw.com.
Tiffany Peintner
FEDERMAN & SHERWOOD
(405) 235-1560
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916364306/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk